FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:CAPN1-TNKS1BP1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: CAPN1-TNKS1BP1
FusionPDB ID: 12869
FusionGDB2.0 ID: 12869
HgeneTgene
Gene symbol

CAPN1

TNKS1BP1

Gene ID

823

85456

Gene namecalpain 1tankyrase 1 binding protein 1
SynonymsCANP|CANP1|CANPL1|SPG76|muCANP|muCLTAB182
Cytomap

11q13.1

11q12.1

Type of geneprotein-codingprotein-coding
Descriptioncalpain-1 catalytic subunitCANP 1calcium-activated neutral proteinase 1calpain 1, (mu/I) large subunitcalpain mu-typecalpain, large polypeptide L1calpain-1 large subunitcell proliferation-inducing gene 30 proteincell proliferation-inducing protein182 kDa tankyrase-1-binding proteintankyrase 1 binding protein 1, 182kDatankyrase 1-binding protein of 182 kDatestis secretory sperm-binding protein Li 206a
Modification date2020032220200313
UniProtAcc

O75808

Main function of 5'-partner protein:
.
Ensembl transtripts involved in fusion geneENST idsENST00000527469, ENST00000279247, 
ENST00000524773, ENST00000527323, 
ENST00000533129, ENST00000533820, 
ENST00000358252, ENST00000532437, 
ENST00000530920, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score13 X 11 X 8=11448 X 8 X 3=192
# samples 138
** MAII scorelog2(13/1144*10)=-3.13750352374993
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(8/192*10)=-1.26303440583379
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: CAPN1 [Title/Abstract] AND TNKS1BP1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: CAPN1 [Title/Abstract] AND TNKS1BP1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)CAPN1(64951063)-TNKS1BP1(57068515), # samples:1
Anticipated loss of major functional domain due to fusion event.CAPN1-TNKS1BP1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CAPN1-TNKS1BP1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CAPN1-TNKS1BP1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
CAPN1-TNKS1BP1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneCAPN1

GO:0006508

proteolysis

2400579|2407243|16411745|21531719

HgeneCAPN1

GO:0050790

regulation of catalytic activity

8954105|9271093

HgeneCAPN1

GO:0097264

self proteolysis

8769305|8954105



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:64951063/chr11:57068515)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across CAPN1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across TNKS1BP1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000533820CAPN1chr1164951063+ENST00000358252TNKS1BP1chr1157068515-134567478869263
ENST00000533820CAPN1chr1164951063+ENST00000532437TNKS1BP1chr1157068515-134367478869263
ENST00000533129CAPN1chr1164951063+ENST00000358252TNKS1BP1chr1157068515-120253175749224
ENST00000533129CAPN1chr1164951063+ENST00000532437TNKS1BP1chr1157068515-120053175749224
ENST00000524773CAPN1chr1164951063+ENST00000358252TNKS1BP1chr1157068515-1227556100774224
ENST00000524773CAPN1chr1164951063+ENST00000532437TNKS1BP1chr1157068515-1225556100774224
ENST00000279247CAPN1chr1164951063+ENST00000358252TNKS1BP1chr1157068515-127059963794243
ENST00000279247CAPN1chr1164951063+ENST00000532437TNKS1BP1chr1157068515-126859963794243
ENST00000527323CAPN1chr1164951063+ENST00000358252TNKS1BP1chr1157068515-1367696207914235
ENST00000527323CAPN1chr1164951063+ENST00000532437TNKS1BP1chr1157068515-1365696207914235

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000533820ENST00000358252CAPN1chr1164951063+TNKS1BP1chr1157068515-0.0471934530.95280653
ENST00000533820ENST00000532437CAPN1chr1164951063+TNKS1BP1chr1157068515-0.0470304750.95296955
ENST00000533129ENST00000358252CAPN1chr1164951063+TNKS1BP1chr1157068515-0.056029410.9439706
ENST00000533129ENST00000532437CAPN1chr1164951063+TNKS1BP1chr1157068515-0.0563128780.9436872
ENST00000524773ENST00000358252CAPN1chr1164951063+TNKS1BP1chr1157068515-0.0556035680.94439644
ENST00000524773ENST00000532437CAPN1chr1164951063+TNKS1BP1chr1157068515-0.0558783450.94412166
ENST00000279247ENST00000358252CAPN1chr1164951063+TNKS1BP1chr1157068515-0.0405294260.95947057
ENST00000279247ENST00000532437CAPN1chr1164951063+TNKS1BP1chr1157068515-0.040587670.9594123
ENST00000527323ENST00000358252CAPN1chr1164951063+TNKS1BP1chr1157068515-0.042979830.95702016
ENST00000527323ENST00000532437CAPN1chr1164951063+TNKS1BP1chr1157068515-0.0432217230.9567783

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for CAPN1-TNKS1BP1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
CAPN1chr1164951063TNKS1BP1chr1157068515531151QSFQNGYAGIFHFQAKLRPRNRSAEE
CAPN1chr1164951063TNKS1BP1chr1157068515556151QSFQNGYAGIFHFQAKLRPRNRSAEE
CAPN1chr1164951063TNKS1BP1chr1157068515599172EWFRTARASRMAMPASSISRPSCAPG
CAPN1chr1164951063TNKS1BP1chr1157068515674192EWFRTARASRMAMPASSISRPSCAPG
CAPN1chr1164951063TNKS1BP1chr1157068515696162QSFQNGYAGIFHFQAKLRPRNRSAEE

Top

Potential FusionNeoAntigen Information of CAPN1-TNKS1BP1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CAPN1-TNKS1BP1_64951063_57068515.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B52:01MAMPASSI0.99930.91111018
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-B39:06FHFQAKLRP0.9930.78131019
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A02:13RMAMPASSI0.97020.6568918
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-A02:22GIFHFQAKL0.96160.5729817
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-A31:02HFQAKLRPR0.94360.78821120
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-A02:04GIFHFQAKL0.93710.7375817
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-A31:02IFHFQAKLR0.93660.5526918
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-A02:17GIFHFQAKL0.93560.5201817
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B07:10RMAMPASSI0.91340.5031918
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-A02:11GIFHFQAKL0.91170.6082817
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A74:11AMPASSISR0.89720.62371120
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A74:09AMPASSISR0.89720.62371120
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A74:03AMPASSISR0.89720.62371120
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-A02:35GIFHFQAKL0.87080.6024817
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A31:02AMPASSISR0.85530.64841120
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-A02:20GIFHFQAKL0.81070.5509817
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B13:02RMAMPASSI0.45290.6809918
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B52:01RMAMPASSI0.1150.9073918
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A74:11RMAMPASSISR0.99620.6433920
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A74:09RMAMPASSISR0.99620.6433920
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A74:03RMAMPASSISR0.99620.6433920
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A31:02RMAMPASSISR0.98290.6573920
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B51:07MAMPASSI0.99920.76861018
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B78:01MAMPASSI0.9990.60211018
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B15:04RMAMPASSI0.98250.9516918
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B73:01SRMAMPASS0.9720.6818817
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-A31:01HFQAKLRPR0.96410.74481120
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-B73:01FHFQAKLRP0.55550.79241019
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A31:01RMAMPASSISR0.99520.6051920
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-C03:17MAMPASSI0.99960.9841018
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B78:02MAMPASSI0.99920.72821018
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-C14:02IFHFQAKL0.73830.9576917
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-C14:03IFHFQAKL0.73830.9576917
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A32:01RMAMPASSI0.98430.9377918
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B15:73RMAMPASSI0.97640.8814918
CAPN1-TNKS1BP1chr1164951063chr1157068515556HLA-A30:01AGIFHFQAK0.96610.8821716
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B15:30RMAMPASSI0.95010.9368918
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A74:01AMPASSISR0.89720.62371120
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-B27:06SRMAMPASSI0.99990.7504818
CAPN1-TNKS1BP1chr1164951063chr1157068515599HLA-A74:01RMAMPASSISR0.99620.6433920

Top

Potential FusionNeoAntigen Information of CAPN1-TNKS1BP1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CAPN1-TNKS1BP1_64951063_57068515.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-0824AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1101AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1105AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1108AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1109AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1110AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1111AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1111GIFHFQAKLRPRNRS823
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1111IFHFQAKLRPRNRSA924
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1112AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1114AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1115AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1119AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1119YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1120AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1124AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1127AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1127YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1128AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1129AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1131AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1131YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1132AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1133AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1137AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1139AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1145AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1145GIFHFQAKLRPRNRS823
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1149AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1151AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1153AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1161AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1162AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1164AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1164GIFHFQAKLRPRNRS823
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1166AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1168AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1169AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1169YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1172AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1172YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1173AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1173YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1174AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1175AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1179AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1180AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1180YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1181AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1181YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1182AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1182YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1186AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1186YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1187AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1187YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1190AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1191AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1193AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1193YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1194AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1195AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1196AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1204YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1209YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1302AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1305AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1307AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1314AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1315YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1316AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1316YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1317YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1323AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1326AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1326YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1329AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1334AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1336AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1337AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1337YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1339AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1341AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1347AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1350AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1356AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1357YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1360AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1362AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1363AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1363GIFHFQAKLRPRNRS823
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1363IFHFQAKLRPRNRSA924
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1373AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1374AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1375HFQAKLRPRNRSAEE1126
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1382AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1382YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1385AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1385YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1386AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1386YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1397AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1399AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1402AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1402YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1403AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1409AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1419AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1424AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1424YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1427AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1430AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1440AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1441AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1441YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1463AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1467AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1467GIFHFQAKLRPRNRS823
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1467YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1477AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1485AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1489AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1489YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1494AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1494YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1498AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1510YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB1-1510GYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0102YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0102GYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0103YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0103GYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0103AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0103NGYAGIFHFQAKLRP419
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0104YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0104GYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0106YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0106GYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0106AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0106NGYAGIFHFQAKLRP419
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0108NYAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0108NGYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0111YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0111GYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0111AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0111NGYAGIFHFQAKLRP419
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0202YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0202GYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0202AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0202NGYAGIFHFQAKLRP419
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0202GIFHFQAKLRPRNRS823
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0203YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0203GYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0203AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0203NGYAGIFHFQAKLRP419
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0204YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0204GYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0204AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0204NGYAGIFHFQAKLRP419
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0205YAGIFHFQAKLRPRN621
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0205GYAGIFHFQAKLRPR520
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0205AGIFHFQAKLRPRNR722
CAPN1-TNKS1BP1chr1164951063chr1157068515556DRB5-0205NGYAGIFHFQAKLRP419

Top

Fusion breakpoint peptide structures of CAPN1-TNKS1BP1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
7710RASRMAMPASSISRCAPN1TNKS1BP1chr1164951063chr1157068515599
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10573YAGIFHFQAKLRPRCAPN1TNKS1BP1chr1164951063chr1157068515556

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of CAPN1-TNKS1BP1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN7710RASRMAMPASSISR-7.9962-8.1096
HLA-B14:023BVN7710RASRMAMPASSISR-5.70842-6.74372
HLA-B52:013W397710RASRMAMPASSISR-6.83737-6.95077
HLA-B52:013W397710RASRMAMPASSISR-4.4836-5.5189
HLA-A11:014UQ27710RASRMAMPASSISR-10.0067-10.1201
HLA-A11:014UQ27710RASRMAMPASSISR-9.03915-10.0745
HLA-A24:025HGA7710RASRMAMPASSISR-6.56204-6.67544
HLA-A24:025HGA7710RASRMAMPASSISR-5.42271-6.45801
HLA-B44:053DX87710RASRMAMPASSISR-7.85648-8.89178
HLA-B44:053DX87710RASRMAMPASSISR-5.3978-5.5112
HLA-A02:016TDR7710RASRMAMPASSISR-3.37154-4.40684
HLA-B14:023BVN10573YAGIFHFQAKLRPR-7.15543-7.26883
HLA-B14:023BVN10573YAGIFHFQAKLRPR-4.77435-5.80965
HLA-B52:013W3910573YAGIFHFQAKLRPR-6.80875-6.92215
HLA-B52:013W3910573YAGIFHFQAKLRPR-4.20386-5.23916
HLA-A11:014UQ210573YAGIFHFQAKLRPR-7.5194-8.5547
HLA-A11:014UQ210573YAGIFHFQAKLRPR-6.9601-7.0735
HLA-A24:025HGA10573YAGIFHFQAKLRPR-7.52403-7.63743
HLA-A24:025HGA10573YAGIFHFQAKLRPR-5.82433-6.85963
HLA-B27:056PYJ10573YAGIFHFQAKLRPR-3.28285-4.31815
HLA-B44:053DX810573YAGIFHFQAKLRPR-5.91172-6.94702
HLA-B44:053DX810573YAGIFHFQAKLRPR-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of CAPN1-TNKS1BP1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
CAPN1-TNKS1BP1chr1164951063chr11570685151018MAMPASSICATTTCCAGGCCAAGCTGCGCCCC
CAPN1-TNKS1BP1chr1164951063chr11570685151019FHFQAKLRPCATTTCCAGGCCAAGCTGCGCCCCCGG
CAPN1-TNKS1BP1chr1164951063chr11570685151120AMPASSISRTTCCAGGCCAAGCTGCGCCCCCGGAAT
CAPN1-TNKS1BP1chr1164951063chr11570685151120HFQAKLRPRTTCCAGGCCAAGCTGCGCCCCCGGAAT
CAPN1-TNKS1BP1chr1164951063chr1157068515716AGIFHFQAKGGCATCTTCCATTTCCAGGCCAAGCTG
CAPN1-TNKS1BP1chr1164951063chr1157068515817GIFHFQAKLATCTTCCATTTCCAGGCCAAGCTGCGC
CAPN1-TNKS1BP1chr1164951063chr1157068515817SRMAMPASSATCTTCCATTTCCAGGCCAAGCTGCGC
CAPN1-TNKS1BP1chr1164951063chr1157068515818SRMAMPASSIATCTTCCATTTCCAGGCCAAGCTGCGCCCC
CAPN1-TNKS1BP1chr1164951063chr1157068515917IFHFQAKLTTCCATTTCCAGGCCAAGCTGCGC
CAPN1-TNKS1BP1chr1164951063chr1157068515918IFHFQAKLRTTCCATTTCCAGGCCAAGCTGCGCCCC
CAPN1-TNKS1BP1chr1164951063chr1157068515918RMAMPASSITTCCATTTCCAGGCCAAGCTGCGCCCC
CAPN1-TNKS1BP1chr1164951063chr1157068515920RMAMPASSISRTTCCATTTCCAGGCCAAGCTGCGCCCCCGGAAT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
CAPN1-TNKS1BP1chr1164951063chr11570685151126HFQAKLRPRNRSAEETTCCAGGCCAAGCTGCGCCCCCGGAATCGCTCAGCTGAGGAGGGA
CAPN1-TNKS1BP1chr1164951063chr1157068515419NGYAGIFHFQAKLRPGGCTATGCCGGCATCTTCCATTTCCAGGCCAAGCTGCGCCCCCGG
CAPN1-TNKS1BP1chr1164951063chr1157068515520GYAGIFHFQAKLRPRTATGCCGGCATCTTCCATTTCCAGGCCAAGCTGCGCCCCCGGAAT
CAPN1-TNKS1BP1chr1164951063chr1157068515621YAGIFHFQAKLRPRNGCCGGCATCTTCCATTTCCAGGCCAAGCTGCGCCCCCGGAATCGC
CAPN1-TNKS1BP1chr1164951063chr1157068515722AGIFHFQAKLRPRNRGGCATCTTCCATTTCCAGGCCAAGCTGCGCCCCCGGAATCGCTCA
CAPN1-TNKS1BP1chr1164951063chr1157068515823GIFHFQAKLRPRNRSATCTTCCATTTCCAGGCCAAGCTGCGCCCCCGGAATCGCTCAGCT
CAPN1-TNKS1BP1chr1164951063chr1157068515924IFHFQAKLRPRNRSATTCCATTTCCAGGCCAAGCTGCGCCCCCGGAATCGCTCAGCTGAG

Top

Information of the samples that have these potential fusion neoantigens of CAPN1-TNKS1BP1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BLCACAPN1-TNKS1BP1chr1164951063ENST00000279247chr1157068515ENST00000358252TCGA-DK-A6B5-01A
BLCACAPN1-TNKS1BP1chr1164951063ENST00000524773chr1157068515ENST00000358252TCGA-DK-A6B5-01A

Top

Potential target of CAR-T therapy development for CAPN1-TNKS1BP1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to CAPN1-TNKS1BP1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to CAPN1-TNKS1BP1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource